Patents by Inventor Bernard Prudhon

Bernard Prudhon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Allele-specific silencing therapy for dynamin 2-related diseases
    Patent number: 11926829
    Abstract: The invention relates to an allele specific siRNA able to silence the expression of only one allele of a heterozygous DNM2 gene, for treating diseases caused by heterozygous mutation and/or overexpression of Dynamin 2.
    Type: Grant
    Filed: February 3, 2021
    Date of Patent: March 12, 2024
    Assignees: ASSOICATION INSTITUT DE MYOLOGIE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Marc Bitoun, Delphine Trochet, Bernard Prudhon
  • ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES
    Publication number: 20210163953
    Abstract: The invention relates to an allele specific siRNA able to silence the expression of only one allele of a heterozygous DNM2 gene, for treating diseases caused by heterozygous mutation anchor overexpression of Dynamin 2.
    Type: Application
    Filed: February 3, 2021
    Publication date: June 3, 2021
    Inventors: Marc BITOUN, Delphine TROCHET, Bernard PRUDHON
  • Allele-specific silencing therapy for Dynamin 2-related diseases
    Patent number: 10947540
    Abstract: The invention relates to an allele specific siRNA able to silence the expression of only one allele of a heterozygous DNM2 gene, for treating diseases caused by heterozygous mutation and/or overexpression of Dynamin 2.
    Type: Grant
    Filed: November 19, 2017
    Date of Patent: March 16, 2021
    Assignees: ASSOCIATION INSTITUT DE MYOLOGIE, INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
    Inventors: Marc Bitoun, Delphine Trochet, Bernard Prudhon
  • ALLELE-SPECIFIC SILENCING THERAPY FOR DYNAMIN 2-RELATED DISEASES
    Publication number: 20190309305
    Abstract: The invention relates to an allele specific siRNA able to silence the expression of only one allele of a heterozygous DNM2 gene, for treating diseases caused by heterozygous mutation and/or overexpression of Dynamin 2.
    Type: Application
    Filed: November 19, 2017
    Publication date: October 10, 2019
    Inventors: Marc BITOUN, Delphine TROCHET, Bernard PRUDHON
  • Myocardium-specific promoter
    Publication number: 20040175699
    Abstract: Myocardium-specific promoter derived from the MYBPC gene of a mammal and comprising the regulatory cis-elements necessary and sufficient to direct the specific expression of a gene in the myocardium. Use for treating myocardial diseases.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 9, 2004
    Inventors: Marc Fiszman, Bernard Prudhon, Yves Fromes